Fresenius Medical Care stock trades at EUR 36.47, volume 33.8 percent below average

Published on 10/08/2026 at 16:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius Medical Care stock stood at EUR 36.47 on October 8, 2026, versus EUR 37.47. Results are due November 3, 2026.

Key points in brief

Fresenius Medical Care stock was at EUR 36.47 at Lang & Schwarz on October 8, 2026, down 2.67 percent from EUR 37.47.
Trading volume stood at 489,814 shares, 33.81 percent below the 740,084-share average.
The stock's USD 11.0 billion market capitalization and 10.98 P/E ratio provide valuation context.
Fresenius Medical Care is scheduled to publish third-quarter 2026 results on November 3, 2026.

Moderner Dialyseraum mit Hämodialysegeräten und Patientenliegen bei Tageslicht — Ein fotorealistisches Bild eines modernen Dialyseraums mit mehreren Hämodialysegeräten und Patientenliegen in Reihe, ruhigem Tageslicht durch große Fenster – typisch für die Behandlungszentren von Fresenius Medical Care AG (ISIN DE0005785802), Illustration mit AI erstellt.

Fresenius Medical Care (ISIN DE0005785802) was trading at EUR 36.47 at Lang & Schwarz on October 8, 2026 at 4:39 p.m. CEST, down 2.67 percent versus the prior close of EUR 37.47. The price report puts the stock below its previous session level while keeping the focus on liquidity, valuation and the next scheduled company date.

Volume remains below its average

Lang & Schwarz showed a bid of EUR 36.46 and an ask of EUR 36.48 at the same timestamp. Trading volume on the primary US listing was 489,814 shares at 10:49 a.m. ET, compared with an average volume of 740,084 shares, a gap of 33.81 percent.

MarketBeat identifies the primary listing as NYSE:FMS. The finance quote showed USD 20.47 for that listing on October 8, 2026, down 1.06 percent from USD 20.69, so the US session provided a separate home-currency reference from the German euro quote.

Range and valuation set the frame

The USD 20.02 to USD 27.64 52-week range places the US-listed price USD 0.45 above its yearly low and USD 7.17 below its yearly high as of October 8, 2026. Those levels describe the stock's recent trading corridor without converting the home-currency range into euros.

Fresenius Medical Care had a market capitalization of USD 11.0 billion and a P/E ratio of 10.98 on October 8, 2026. The trailing dividend yield was 0.04 percent. For comparison, DaVita carried a USD 11.3 billion market capitalization and a 15.51 P/E ratio, while Baxter International had a USD 12.2 billion market capitalization and a negative 11.61 P/E ratio on the same date.

Comparison with peers

Fresenius Medical Care: minus 1.06 percent, P/E 10.98, market capitalization USD 11.0 billion.

DaVita: minus 0.18 percent, P/E 15.51, market capitalization USD 11.3 billion.

Baxter International: minus 1.25 percent, P/E minus 11.61, market capitalization USD 12.2 billion.

November results date is set

The company's investor calendar states that third-quarter 2026 financial results will be published on November 3, 2026, according to Fresenius Medical Care. That date is the next clearly scheduled reporting point for the stock and gives the current price report a defined calendar marker.

FMC stock remains below its yearly high

Fresenius Medical Care's euro quote was trading at EUR 36.47 at Lang & Schwarz on October 8, 2026 at 4:39 p.m. CEST, versus the EUR 37.47 prior close. The further course of trading is shown by the continuously updated real-time quote of Fresenius Medical Care stock.